EPS15
Basic information
Region (hg38): 1:51354263-51519328
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EPS15 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 39 | 40 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 39 | 1 | 0 |
Variants in EPS15
This is a list of pathogenic ClinVar variants found in the EPS15 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-51356744-C-G | not specified | Uncertain significance (May 29, 2024) | ||
1-51356789-C-T | not specified | Uncertain significance (Aug 17, 2022) | ||
1-51356822-C-T | not specified | Uncertain significance (Jun 12, 2023) | ||
1-51356828-T-C | not specified | Uncertain significance (Sep 26, 2024) | ||
1-51356840-A-G | not specified | Uncertain significance (Aug 11, 2022) | ||
1-51361175-C-T | not specified | Uncertain significance (Dec 17, 2021) | ||
1-51361176-T-A | not specified | Uncertain significance (Feb 15, 2023) | ||
1-51361194-T-C | not specified | Uncertain significance (Feb 02, 2024) | ||
1-51361211-T-C | not specified | Uncertain significance (Aug 05, 2024) | ||
1-51361283-C-T | not specified | Uncertain significance (Oct 28, 2023) | ||
1-51361310-A-G | not specified | Uncertain significance (Aug 02, 2022) | ||
1-51363962-T-G | not specified | Uncertain significance (Oct 16, 2024) | ||
1-51363965-T-C | not specified | Uncertain significance (Jun 21, 2023) | ||
1-51364019-C-G | not specified | Uncertain significance (Jan 08, 2024) | ||
1-51364024-T-C | not specified | Uncertain significance (Nov 20, 2024) | ||
1-51366020-G-A | not specified | Uncertain significance (Aug 12, 2021) | ||
1-51399048-T-C | not specified | Uncertain significance (Jan 26, 2023) | ||
1-51399057-G-A | not specified | Uncertain significance (Feb 14, 2023) | ||
1-51399078-G-A | not specified | Uncertain significance (Jan 06, 2023) | ||
1-51400939-C-T | not specified | Uncertain significance (Aug 21, 2024) | ||
1-51402437-C-T | not specified | Uncertain significance (Oct 13, 2023) | ||
1-51402486-G-C | not specified | Uncertain significance (Feb 10, 2022) | ||
1-51402492-T-A | not specified | Uncertain significance (Jan 03, 2024) | ||
1-51402522-C-G | not specified | Uncertain significance (May 15, 2024) | ||
1-51405957-T-C | not specified | Uncertain significance (Jan 17, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EPS15 | protein_coding | protein_coding | ENST00000371733 | 25 | 165066 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00348 | 0.997 | 125719 | 0 | 28 | 125747 | 0.000111 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.781 | 402 | 449 | 0.896 | 0.0000213 | 5930 |
Missense in Polyphen | 110 | 152.55 | 0.72108 | 2081 | ||
Synonymous | 0.369 | 157 | 163 | 0.963 | 0.00000847 | 1635 |
Loss of Function | 4.56 | 14 | 48.2 | 0.291 | 0.00000214 | 629 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000178 | 0.000178 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000168 | 0.000149 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000137 | 0.000131 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in cell growth regulation. May be involved in the regulation of mitogenic signals and control of cell proliferation. Involved in the internalization of ligand-inducible receptors of the receptor tyrosine kinase (RTK) type, in particular EGFR. Plays a role in the assembly of clathrin-coated pits (CCPs). Acts as a clathrin adapter required for post-Golgi trafficking. Seems to be involved in CCPs maturation including invagination or budding. Involved in endocytosis of integrin beta- 1 (ITGB1) and transferrin receptor (TFR); internalization of ITGB1 as DAB2-dependent cargo but not TFR seems to require association with DAB2. {ECO:0000269|PubMed:16903783, ECO:0000269|PubMed:18362181, ECO:0000269|PubMed:19458185, ECO:0000269|PubMed:22648170}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving EPS15 is found in acute leukemias. Translocation t(1;11)(p32;q23) with KMT2A/MLL1. The result is a rogue activator protein.;
- Pathway
- Endocytosis - Homo sapiens (human);VEGFA-VEGFR2 Signaling Pathway;Ebola Virus Pathway on Host;Ebola Virus Pathway on Host;EGF-EGFR Signaling Pathway;Disease;Signal Transduction;Vesicle-mediated transport;endocytotic role of ndk phosphins and dynamin;Membrane Trafficking;Infectious disease;EGFR downregulation;Signaling by EGFR;Clathrin-mediated endocytosis;EGFR1;Cargo recognition for clathrin-mediated endocytosis;Notch signaling pathway;Negative regulation of MET activity;Signaling by MET;Signaling by Receptor Tyrosine Kinases;Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met);Internalization of ErbB1;InlB-mediated entry of Listeria monocytogenes into host cell;Listeria monocytogenes entry into host cells
(Consensus)
Recessive Scores
- pRec
- 0.434
Intolerance Scores
- loftool
- 0.667
- rvis_EVS
- 0.47
- rvis_percentile_EVS
- 78.83
Haploinsufficiency Scores
- pHI
- 0.598
- hipred
- Y
- hipred_score
- 0.731
- ghis
- 0.549
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.704
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Eps15
- Phenotype
- hematopoietic system phenotype; immune system phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- positive regulation of receptor recycling;Golgi to endosome transport;epidermal growth factor receptor signaling pathway;cell population proliferation;vesicle organization;receptor-mediated endocytosis of virus by host cell;endocytic recycling;negative regulation of epidermal growth factor receptor signaling pathway;regulation of cell population proliferation;viral entry into host cell;clathrin coat assembly;membrane organization;postsynaptic neurotransmitter receptor internalization
- Cellular component
- cytosol;plasma membrane;clathrin-coated pit;basal plasma membrane;membrane;aggresome;apical plasma membrane;AP-2 adaptor complex;early endosome membrane;intracellular membrane-bounded organelle;ciliary membrane;postsynapse;glutamatergic synapse
- Molecular function
- calcium ion binding;protein binding;SH3 domain binding;polyubiquitin modification-dependent protein binding;cargo receptor activity;identical protein binding;cadherin binding